期刊
ANNALS OF HEMATOLOGY
卷 94, 期 8, 页码 1319-1326出版社
SPRINGER
DOI: 10.1007/s00277-015-2364-5
关键词
MRD; Multiparametric flowcytometry; Elderly leukemia
类别
资金
- Lazio Regional Agency for Transplantation and Related Diseases (IG) [971/E]
- Ministero Istruzione Universita Ricerca Projects Of National Relevance (PRIN, IG) [20110AX25X7]
- Associazione Italiana Ricerca sul Cancro (IG) [10555]
In the present analysis, we evaluated whether in elderly acute myeloid leukemia (AML) patients (> 60 years), minimal residual disease (MRD) assessed by flow cytometry may have a role in guiding choice of postremission strategies. We analyzed 149 young and 61 elderly adults who achieved morphological CR after induction course of EORTC/GIMEMA protocols. Elderly patients reached a postconsolidation MRD negative status less frequently than younger ones (11 vs 28 %, p = 0.009). MRD negativity resulted in a longer 5-year disease-free survival (DFS) both in elderly (57 vs 13 %, p = 0.0197) and in younger patients (56 vs 31 %, p = 0.0017). Accordingly, 5-year cumulative incidence of relapse (CIR) of both elderly (83 vs 42 %, p = 0.045) and younger patients (59 vs 24 % p = NS) who were MRD positive doubled that of MRD negative ones. Nevertheless, CIR of MRD negative elderly patients was twofold higher than that of younger MRD negative ones (42 vs 24 %, p = NS). In conclusion, elderly patients in whom chemotherapy yields a MRD negative CR have duration of DFS and rate of CIR significantly better than those who remain MRD positive. Nonetheless, the high CIR rate observed in the elderly suggests that MRD negativity might have different therapeutic implications in this population than in the younger counterpart.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据